Salvatore Colangelo
A5025673007- Coronary Interventions and Diagnostics
- Acute Myocardial Infarction Research
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiac Imaging and Diagnostics
- Cardiac, Anesthesia and Surgical Outcomes
- Cardiac Valve Diseases and Treatments
- Atrial Fibrillation Management and Outcomes
- Venous Thromboembolism Diagnosis and Management
- Vascular Procedures and Complications
- Mechanical Circulatory Support Devices
- Cardiac Structural Anomalies and Repair
- Aortic aneurysm repair treatments
- Peripheral Artery Disease Management
- Acute Kidney Injury Research
- Cardiac Arrhythmias and Treatments
- Central Venous Catheters and Hemodialysis
- Cardiac and Coronary Surgery Techniques
- Coronary Artery Anomalies
- Cardiac Arrest and Resuscitation
- Vascular anomalies and interventions
- Aortic Disease and Treatment Approaches
- Orthopedic Surgery and Rehabilitation
- Cardiovascular Issues in Pregnancy
- Cardiac Health and Mental Health
- Atherosclerosis and Cardiovascular Diseases
Ospedale San Giovanni Bosco
2013-2023
Società Italiana di Cardiologia Interventistica
2022
Universitat de Barcelona
2018
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
2017
Azienda Ospedaliero Universitaria San Giovanni Battista
2006-2012
Centro Cardiologico Monzino
2010
Ospedale Maggiore
2010
Ospedale Maria Vittoria
2010
University of Brescia
2009
Florida College
2009
Inhibition of platelet aggregation after aspirin or clopidogrel intake varies greatly among patients, and previous studies have suggested that poor response to oral antiplatelet agents may increase the risk thrombotic events, especially coronary angioplasty. Whether this reflects suboptimal inhibition per se, which might benefit from more potent such as tirofiban, is unknown.We screened 1277 patients enroll 93 aspirin, 147 clopidogrel, 23 dual responders, based on a point-of-care assay, who...
This study was undertaken to evaluate the accuracy of four different risk-adjusted models in predicting mortality individual patients who are undergoing coronary artery by-pass graft surgery. In last decade several stratify before open heart surgery, according factors affecting mortality, were developed with aim retrospectively comparing outcomes based on reliable stratification case-mix, and prospectively identifying high risk as a basis for meaningful informed consent counseling.The...
Objective: The aim of this study is to determine if a preoperative risk stratification model can identify different surgical costs. Methods: Four hundred and eighty-eight patients undergoing open heart surgery between March 2000 2001 were classified with the EuroSCORE model. Direct variable costs prospectively collected, team excluded. multivariate analysis was used find variables independently associated Results: Of 488 enrolled 342 (70%) males, mean age 65±10 years, 57 (12%) had myocardial...
While bleeding in patients with STEMI undergoing primary percutaneous coronary intervention (pPCI) is known to be associated poor outcomes, the differential prognostic impact of access-site related versus non bleedings unknown. We aimed assess relative bleeding, as compared related, on 12-month clinical outcome for STEMI.Thirty-day endpoints, stratified into access-site, were examined according TIMI scale 744 enrolled MULTISTRATEGY trial. major or minor complications occurred 56 (7.5%)...
AimsTo analyse the clinical outcome at 4 years in patients with coronary artery disease treated bare metal stents (BMS) vs. BMS and oral prednisone, or drug-eluting (DES), all assuming similar adjunctive medical treatment.
Abstract Objectives Culprit plaque characteristics in young patients who experience an Acute Coronary Syndrome (ACS) evaluated by OCT (Optical Coherence Tomography) have to be defined. The OCT‐FORMIDABLE is a multicentre retrospective registry enrolling consecutive with ACS performed 9 European centres. Methods Patients were divided two groups according age at presentation: juvenile‐ACS (age ≤ 50 years) and not > years). Primary end‐point was the prevalence of rupture (PR). Secondary end...
Background: Treatment of long coronary stenoses (LCS) with tapered drug-eluting stents (LT-DES) would offer clinical and economic benefits. However, the feasibility an interventional strategy based upon systematic LCS treatment LT-DES has not been evaluated so far. Methods: We performed a multicenter prospective study including consecutive patients with: 1) An > 25 mm at angiography; 2) attempt to fix single BioMime Morph ™ stent, novel available from 30 60 long. The primary efficacy...